Table 5.

Glycemic management, complications, and use of diabetes technology in subjects with T1DM during ICI therapy.

	Case, n (%)	Control, n (%)
Use of diabetes technology
CGM	5 (45.5%)	0
Insulin pump	8 (72.7%)	0
None	3 (27.3%)	0
Change in insulin regimen during ICI
Yes	6 (54.5%)	0
No	3 (27.3%)	0
Not documented	2 (18.2%)	0
ED visit or hospitalization for T1DM
Yes	0 (0%)	0
No	11 (100.0%)	0
ED visit or hospitalization
Yes	0 (0%)	0
No	11 (100.0%)	0

CGM, continuous glucose monitor; ED, emergency department.